Stefano Cereda
YOU?
Author Swipe
View article: Immunotherapy in small bowel adenocarcinoma: a potential role?
Immunotherapy in small bowel adenocarcinoma: a potential role? Open
Small bowel adenocarcinoma (SBA) is a rare tumor with an unfavorable prognosis, and due to its rarity, few studies on its treatment are available. Chemotherapy remains the standard of treatment in advanced disease. Recently immunotherapy h…
View article: Data from (Ir)relevance of Metformin Treatment in Patients with Metastatic Pancreatic Cancer: An Open-Label, Randomized Phase II Trial
Data from (Ir)relevance of Metformin Treatment in Patients with Metastatic Pancreatic Cancer: An Open-Label, Randomized Phase II Trial Open
Purpose: We aimed to assess the safety and efficacy of metformin for treating patients with metastatic pancreatic cancer and to identify endocrine and metabolic phenotypic features or tumor molecular markers associated with sensitivity to …
View article: Online-only supplementary files from (Ir)relevance of Metformin Treatment in Patients with Metastatic Pancreatic Cancer: An Open-Label, Randomized Phase II Trial
Online-only supplementary files from (Ir)relevance of Metformin Treatment in Patients with Metastatic Pancreatic Cancer: An Open-Label, Randomized Phase II Trial Open
Supplementary table 1. HOMA indexes at baseline among patients according to glucose tolerance Supplementary table 2. Cox proportional hazard models of the predictors of mortality and disease progression by univariate and multivariate analy…
View article: Data from (Ir)relevance of Metformin Treatment in Patients with Metastatic Pancreatic Cancer: An Open-Label, Randomized Phase II Trial
Data from (Ir)relevance of Metformin Treatment in Patients with Metastatic Pancreatic Cancer: An Open-Label, Randomized Phase II Trial Open
Purpose: We aimed to assess the safety and efficacy of metformin for treating patients with metastatic pancreatic cancer and to identify endocrine and metabolic phenotypic features or tumor molecular markers associated with sensitivity to …
View article: Online-only supplementary files from (Ir)relevance of Metformin Treatment in Patients with Metastatic Pancreatic Cancer: An Open-Label, Randomized Phase II Trial
Online-only supplementary files from (Ir)relevance of Metformin Treatment in Patients with Metastatic Pancreatic Cancer: An Open-Label, Randomized Phase II Trial Open
Supplementary table 1. HOMA indexes at baseline among patients according to glucose tolerance Supplementary table 2. Cox proportional hazard models of the predictors of mortality and disease progression by univariate and multivariate analy…
View article: scikit-optimize/scikit-optimize: v0.5.2
scikit-optimize/scikit-optimize: v0.5.2 Open
Version 0.5.2 Bug fixes Separated n_points from n_jobs in BayesSearchCV. Dimensions now support boolean np.arrays. Maintenance matplotlib is now an optional requirement (install with pip install 'scikit-optimize[plots]')
View article: scikit-optimize/scikit-optimize: v0.5.1 - re-release
scikit-optimize/scikit-optimize: v0.5.1 - re-release Open
This release super-seeds v0.5. We made a mistake tagging the v0.5rc1 on PyPI and releasing this to replace v0.5.
View article: Prognostic and predictive role of EGFR pathway alterations in biliary cancer patients treated with chemotherapy and anti-EGFR
Prognostic and predictive role of EGFR pathway alterations in biliary cancer patients treated with chemotherapy and anti-EGFR Open
The association of anti-EGFR to gemcitabine and oxaliplatin (GEMOX) chemotherapy did not improve survival in biliary tract carcinoma (BTC) patients. Multiple mechanisms might be involved in the resistance to anti-EGFR. Here, we explored th…
View article: Chemoembolization with drug eluting beads preloaded with irinotecan (DEBIRI) <i>vs</i> doxorubicin (DEBDOX) as a second line treatment for liver metastases from cholangiocarcinoma: a preliminary study
Chemoembolization with drug eluting beads preloaded with irinotecan (DEBIRI) <i>vs</i> doxorubicin (DEBDOX) as a second line treatment for liver metastases from cholangiocarcinoma: a preliminary study Open
In our preliminary experience, DEBIRI was more effective than DEBDOX as a second-line treatment for hepatic metastases from CCA. Antipain drug administration and the use of the microcatheter led to a good treatment tolerability and a low c…